Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Multicenter Observational Study to Assess the Incidence and Features of COVID-19 and the Response to COVID-19 Vaccination in Fragile Patients"

NCT05222139 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT05222139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Multicenter Observational Study to Assess the Incidence and Features of COVID-19 and the Response to COVID-19 Vaccination in Fragile Patients"
Lead sponsor
University of Bologna
Phase
Observational
Overall status
Completed
Start date
May 24, 2021
Completion date
November 30, 2024
Enrollment
8,894 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

breakthrough infection, sars cov 2 infection, vaccination; infection